Flow cytometry results showed that compared with the ANXA114‐26 group, the apoptotic cells in the ANXA114‐26+OE‐Cyclin D1 group decreased, indicating that overexpression of Cyclin D1 could reverse the inhibitory effect of ANXA114‐26 on ovarian cancer cells (Figure 5I). This evidence concerns the gene CCND1 and ovarian cancer.